Sanibel Captiva Trust Company’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.07M Buy
13,186
+961
+8% +$144K 0.05% 194
2026
Q1
$1.87M Buy
12,225
+152
+1% +$23.3K 0.05% 187
2025
Q4
$1.66M Buy
12,073
+992
+9% +$130K 0.05% 190
2025
Q3
$1.42M Sell
11,081
-350
-3% -$42.7K 0.04% 208
2025
Q2
$1.38M Buy
11,431
+530
+5% +$59.7K 0.04% 199
2025
Q1
$1.22M Sell
10,901
-939
-8% -$100K 0.04% 209
2024
Q4
$1.15M Sell
11,840
-405
-3% -$43.2K 0.04% 212
2024
Q3
$1.41M Hold
12,245
0.05% 195
2024
Q2
$1.3M Hold
12,245
0.04% 189
2024
Q1
$1.18M Sell
12,245
-3,053
-20% -$313K 0.04% 191
2023
Q4
$1.54M Buy
+15,298
New +$1.48M 0.06% 163

Other funds holding NVS

Sanibel Captiva Trust Company's NVS Position: Q2 2026 in Review

Sanibel Captiva Trust Company increased its Novartis (NVS) stake by 7.9% in Q2 2026, buying an estimated $144K and bringing the position to 13,186 shares worth $2.07M. The position accounts for 0.05% of the portfolio, ranked #194.

Sanibel Captiva Trust Company first reported a position in NVS in Q4 2023 and has held it in 11 quarters since. 1,612 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • Sanibel Captiva Trust Company held 13,186 shares of Novartis worth $2.07M as of Q2 2026.
  • Sanibel Captiva Trust Company bought 961 Novartis shares in Q2 2026, an estimated $144K.
  • Novartis made up 0.05% of Sanibel Captiva Trust Company's portfolio in Q2 2026, its #194 holding.
  • Sanibel Captiva Trust Company first reported a position in Novartis in Q4 2023 and has held it in 11 quarters since.
  • 1,612 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Sanibel Captiva Trust Company's 13F filing for Q2 2026, filed 27 Jul 2026.